T2 Biosystems, Inc. - stock earnings
TTOO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -15.4 million USD | 1.5 million USD |
| 2023Q2 | -6.3 million USD | 2.0 million USD |
| 2023Q1 | -20.0 million USD | 2.1 million USD |
| 2022Q4 | -11.5 million USD | 5.5 million USD |
| 2022Q3 | -19.0 million USD | 3.7 million USD |
| 2022Q2 | -21.0 million USD | 5.9 million USD |
| 2022Q1 | -18.1 million USD | 7.2 million USD |
| 2021Q4 | -12.1 million USD | 7.0 million USD |
| 2021Q3 | -14.0 million USD | 7.4 million USD |
| 2021Q2 | -12.5 million USD | 6.7 million USD |
| 2021Q1 | -10.7 million USD | 7.0 million USD |
| 2020Q4 | -9.9 million USD | 7.8 million USD |
| 2020Q3 | -11.3 million USD | 5.2 million USD |
| 2020Q2 | -10.7 million USD | 2.6 million USD |
| 2020Q1 | -14.9 million USD | 2.5 million USD |
| 2019Q4 | -14.0 million USD | 3.1 million USD |
| 2019Q3 | -14.2 million USD | 1.7 million USD |
| 2019Q2 | -15.6 million USD | 1.8 million USD |
| 2019Q1 | -15.1 million USD | 1.8 million USD |
| 2018Q4 | -15.1 million USD | 1.8 million USD |
| 2018Q3 | -10.8 million USD | 2.5 million USD |
| 2018Q2 | -12.3 million USD | 3.9 million USD |
| 2018Q1 | -12.9 million USD | 2.3 million USD |
| 2017Q4 | -18.2 million USD | 1.7 million USD |
| 2017Q3 | -14.1 million USD | 1.1 million USD |
| 2017Q2 | -15.5 million USD | 956000 USD |
| 2017Q1 | -14.7 million USD | 941000 USD |
| 2016Q4 | -14.5 million USD | 910000 USD |
| 2016Q3 | -12.8 million USD | 1.1 million USD |
| 2016Q2 | -14.0 million USD | 990000 USD |
| 2016Q1 | -13.4 million USD | 1.1 million USD |
| 2015Q4 | -12.0 million USD | 1.0 million USD |
| 2015Q3 | -11.6 million USD | 1.0 million USD |
| 2015Q2 | -11.0 million USD | 564000 USD |
| 2015Q1 | -10.6 million USD | 188000 USD |
| 2014Q4 | -9.1 million USD | 119000 USD |
| 2014Q3 | -8.1 million USD | ? USD |
| 2014Q2 | -7.3 million USD | ? USD |
| 2014Q1 | -6.9 million USD | ? USD |
| 2013Q4 | -6.4 million USD | 55000 USD |
| 2013Q3 | -4.6 million USD | 91000 USD |
| 2013Q2 | -5.0 million USD | 120000 USD |
| 2013Q1 | -4.6 million USD | ? USD |
| 2012Q4 | ? USD | 19000 USD |
TTOO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -49.8 million USD | 11.0 million USD |
| 2022 | -63.4 million USD | 22.3 million USD |
| 2021 | -53.5 million USD | 28.1 million USD |
| 2020 | -49.2 million USD | 18.1 million USD |
| 2019 | -63.1 million USD | 8.3 million USD |
| 2018 | -51.2 million USD | 10.5 million USD |
| 2017 | -62.4 million USD | 4.7 million USD |
| 2016 | -54.8 million USD | 4.1 million USD |
| 2015 | -45.3 million USD | 2.8 million USD |
| 2014 | -31.4 million USD | 119000 USD |
| 2013 | -20.6 million USD | 266000 USD |
| 2012 | -14.5 million USD | 19000 USD |
TTOO
Price: $3
52 week price:
Payout Ratio Range:
Earnings Per Share: -35.62 USD
P/E Ratio: -0.14
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 168600
Ebitda: -11.7 millionMarket Capitalization: 14.0 million